What is a stock summary page? Click here for an overview.
Business Description
Vycor Medical Inc
NAICS : 339112
SIC : 3841
ISIN : US92921M2035
Description
Vycor Medical Inc is engaged in designing, developing and marketing medical devices for use in neurosurgery in the United States. It has developed ViewSite Brain Access System, which helps to reduce brain tissue trauma that arises from excessive pressure at the edges of the blade. It also provides non-invasive rehabilitation therapies for patients having disorders resulting from neurological brain damage caused by a stroke. The company operates through two segments: Vycor Medical, which focuses on devices for neurosurgery; and NovaVision, which focuses on neurostimulation therapies and diagnostic devices for the treatment and screening of visual field loss. The majority of the revenue comes from the Vycor Medical segment in the United States.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.15 | |||||
| Equity-to-Asset | -3.43 | |||||
| Debt-to-Equity | -0.29 | |||||
| Debt-to-EBITDA | -43.32 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -46.19 | |||||
| Beneish M-Score | -3.77 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.8 | |||||
| 3-Year EPS without NRI Growth Rate | 26.3 | |||||
| 3-Year Book Growth Rate | -12.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 0.88 | |||||
| 14-Day RSI | 11.88 | |||||
| 3-1 Month Momentum % | -1.29 | |||||
| 6-1 Month Momentum % | -12.66 | |||||
| 12-1 Month Momentum % | -25.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.16 | |||||
| Quick Ratio | 0.12 | |||||
| Cash Ratio | 0.03 | |||||
| Days Inventory | 515.83 | |||||
| Days Sales Outstanding | 61.05 | |||||
| Days Payable | 331.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6 | |||||
| Shareholder Yield % | -3.23 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 89.53 | |||||
| Operating Margin % | -6.45 | |||||
| Net Margin % | -13.45 | |||||
| FCF Margin % | 7.21 | |||||
| ROA % | -19.07 | |||||
| ROIC % | -7.48 | |||||
| 3-Year ROIIC % | 12683.33 | |||||
| ROC (Joel Greenblatt) % | -23.24 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Owner-Earnings | 64.78 | |||||
| PS Ratio | 1.51 | |||||
| Price-to-Free-Cash-Flow | 21.6 | |||||
| Price-to-Operating-Cash-Flow | 21.6 | |||||
| EV-to-EBIT | -35.48 | |||||
| EV-to-EBITDA | -123.48 | |||||
| EV-to-Revenue | 2.14 | |||||
| EV-to-FCF | 31.01 | |||||
| Price-to-GF-Value | 0.65 | |||||
| Price-to-Median-PS-Value | 0.54 | |||||
| Earnings Yield (Greenblatt) % | -2.82 | |||||
| FCF Yield % | 4.81 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:VYCO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vycor Medical Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.442 | ||
| EPS (TTM) ($) | -0.02 | ||
| Beta | -0.4 | ||
| 3-Year Sharpe Ratio | 0.33 | ||
| 3-Year Sortino Ratio | 0.63 | ||
| Volatility % | 66.15 | ||
| 14-Day RSI | 11.88 | ||
| 14-Day ATR ($) | 0.001501 | ||
| 20-Day SMA ($) | 0.067674 | ||
| 12-1 Month Momentum % | -25.81 | ||
| 52-Week Range ($) | 0.0325 - 0.1279 | ||
| Shares Outstanding (Mil) | 33.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vycor Medical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vycor Medical Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vycor Medical Inc Frequently Asked Questions
What is Vycor Medical Inc(VYCO)'s stock price today?
The current price of VYCO is $0.06. The 52 week high of VYCO is $0.13 and 52 week low is $0.03.
When is next earnings date of Vycor Medical Inc(VYCO)?
The next earnings date of Vycor Medical Inc(VYCO) is .
Does Vycor Medical Inc(VYCO) pay dividends? If so, how much?
Vycor Medical Inc(VYCO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers